theodi/ndl-core-corpus huggingface dataset:
National Lung Cancer Audit State of the Nation report 2023 - data tables
Source: data.gov.uk (2023-04-17)

National Lung Cancer Audit State of the Nation Report 2023. The National Lung Cancer Audit (NLCA) evaluates how the care received by patients diagnosed with lung cancer in England and Wales compares with current recommended practice and provides information that supports healthcare providers, commissioners, and regulators to improve the care for patients. The NLCA reports a set of process and outcome measures that cover important aspects of the care pathway for patients with lung cancer.

In the first NLCA State of the Nation report, we give an overview of the patterns of care and outcomes for 34,478 patients diagnosed with lung cancer in England in 2021. A separate section provides detailed results on the care received by 2,244 patients diagnosed in Wales in 2020 and 2021.

The report describes the results of an analysis using data provided by the National Cancer Registration and Analysis Service (NCRAS) and the Welsh Cancer Network. It summarises the performance of lung cancer services in 2021, and compares this to the situation in 2019 and 2020.

Individual provider results are available. These enable regional and national comparisons to support local QI. In addition, there is a patient and public version of the report available.
NPDA 2020-21 Unit, ICS, regional and country level data
Source: data.gov.uk (2024-05-31)

National Paediatric Diabetes Audit 2020 - 2021. The excel file contains unit, regional and national level data obtained from the National Paediatric Diabetes Audit 2020-2021.
Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2020 and the 31 March 2021.
Data are included for the seven key health checks:
• Glycated Haemoglobin A1c (HbA1c)
• Body Mass Index (BMI)
• Thyroid
• Blood pressure
• Urinary albumin
• Foot examination
• Eye screening.

Data on other health checks include:
• Psychological assessment
• Offering of immunisation against influenza
• Advice about managing diabetes (‘sick-day rules’)
• Using (or trained to use) blood ketone testing strips and a meter
• Cholesterol
• Additional dietetic support

Data are included for health checks at diagnosis
• Screening for autoimmune disease (coeliac and thyroid disease) 
• Provision of Level 3 carbohydrate-counting education

Data on outcomes of care include:
• HbA1c target measurements
• Small vessel (microvascular) disease
• Large vessel (macrovascular) disease
• Autoimmune disease (coeliac and thyroid disease)

The data were first published in 2022 alongside the National Paediatric Diabetes Audit Report 2020-2021 Data suppressed due to small numbers (<5).

For further information and details on the audit please refer to:
• National Paediatric Diabetes Audit Annual Reports: https://www.rcpch.ac.uk/resources/npda-annual-reports
• NPDA results online: http://npda-results.rcpch.ac.uk/default.aspx
• The RCPCH website: https://www.rcpch.ac.uk/npda
NPDA 2020-21 CCG level data
Source: data.gov.uk (2024-05-31)

National Paediatric Diabetes Audit 2020 - 2021. The excel file contains unit, regional and national level data obtained from the National Paediatric Diabetes Audit 2020-2021.
Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2020 and the 31 March 2021.
Data are included for the seven key health checks:
• Glycated Haemoglobin A1c (HbA1c)
• Body Mass Index (BMI)
• Thyroid
• Blood pressure
• Urinary albumin
• Foot examination
• Eye screening.

Data on other health checks include:
• Psychological assessment
• Offering of immunisation against influenza
• Advice about managing diabetes (‘sick-day rules’)
• Using (or trained to use) blood ketone testing strips and a meter
• Cholesterol
• Additional dietetic support

Data are included for health checks at diagnosis
• Screening for autoimmune disease (coeliac and thyroid disease) 
• Provision of Level 3 carbohydrate-counting education

Data on outcomes of care include:
• HbA1c target measurements
• Small vessel (microvascular) disease
• Large vessel (macrovascular) disease
• Autoimmune disease (coeliac and thyroid disease)

The data were first published in 2022 alongside the National Paediatric Diabetes Audit Report 2020-2021 Data suppressed due to small numbers (<5).

For further information and details on the audit please refer to:
• National Paediatric Diabetes Audit Annual Reports: https://www.rcpch.ac.uk/resources/npda-annual-reports
• NPDA results online: http://npda-results.rcpch.ac.uk/default.aspx
• The RCPCH website: https://www.rcpch.ac.uk/npda
NPDA 2020-21 ICS level data
Source: data.gov.uk (2024-05-31)

National Paediatric Diabetes Audit 2020 - 2021. The excel file contains unit, regional and national level data obtained from the National Paediatric Diabetes Audit 2020-2021.
Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2020 and the 31 March 2021.
Data are included for the seven key health checks:
• Glycated Haemoglobin A1c (HbA1c)
• Body Mass Index (BMI)
• Thyroid
• Blood pressure
• Urinary albumin
• Foot examination
• Eye screening.

Data on other health checks include:
• Psychological assessment
• Offering of immunisation against influenza
• Advice about managing diabetes (‘sick-day rules’)
• Using (or trained to use) blood ketone testing strips and a meter
• Cholesterol
• Additional dietetic support

Data are included for health checks at diagnosis
• Screening for autoimmune disease (coeliac and thyroid disease) 
• Provision of Level 3 carbohydrate-counting education

Data on outcomes of care include:
• HbA1c target measurements
• Small vessel (microvascular) disease
• Large vessel (macrovascular) disease
• Autoimmune disease (coeliac and thyroid disease)

The data were first published in 2022 alongside the National Paediatric Diabetes Audit Report 2020-2021 Data suppressed due to small numbers (<5).

For further information and details on the audit please refer to:
• National Paediatric Diabetes Audit Annual Reports: https://www.rcpch.ac.uk/resources/npda-annual-reports
• NPDA results online: http://npda-results.rcpch.ac.uk/default.aspx
• The RCPCH website: https://www.rcpch.ac.uk/npda